Jade Biosciences (JBIO) Accounts Payables (2020 - 2026)

Jade Biosciences' Accounts Payables history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• Quarterly Accounts Payables rose 5666.67% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 5666.67% YoY) and the FY2025 annual result came in at $2.2 million, up 66.74% from the prior year.
• Accounts Payables was $4.0 million for Q1 2026 at Jade Biosciences, up from $2.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $7.6 million in Q2 2025 and bottomed at $69000.0 in Q1 2025.
• A 5-year average of $3.1 million and a median of $2.9 million in 2022 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2025 — Accounts Payables sank 97.92% — and 2026, when it surged 5666.67%.
• Jade Biosciences' Accounts Payables stood at $2.6 million in 2022, then fell by 6.95% to $2.4 million in 2023, then slumped by 46.16% to $1.3 million in 2024, then soared by 66.74% to $2.2 million in 2025, then surged by 84.98% to $4.0 million in 2026.
• Business Quant data shows JBIO's Accounts Payables at $4.0 million in Q1 2026, $2.2 million in Q4 2025, and $1.3 million in Q3 2025.